Key Takeaways
- AG1 is rolling out to nearly 10,000 retail storefronts across Walmart, Target, and Kroger, shifting away from an exclusive direct-to-consumer model.
- Generative and agentic search engines query peer-reviewed scientific studies rather than influencer endorsements, making published trials the primary driver of product discovery.
- AG1 began deploying agentic internal workflows two and a half years ago across customer support triage, formulation research, and supply-chain traceability.
- Operational savings from automated support do not pad margins; AG1 uses the retained capital to fund clinical trials and customer retention.
The Death of the Influencer Ad Read
For a decade, consumer wellness brands bought growth through podcast sponsorships and Instagram endorsements. AG1 built a massive subscription business doing exactly that. But that playbook has hit a ceiling. When consumers ask an AI agent what supplement to buy, the bot does not care who sponsored a podcast episode. It reads PubMed.
This fundamentally alters customer acquisition. In the old direct-to-consumer playbook, marketing spend paid creators to manufacture social proof. In the new search environment, the technical data is the copy. If an algorithm synthesizes double-blind studies to answer a user prompt, marketing dollars spent on unverified claims evaporate. Cole notes that “the science is the marketing. The science is the search result and that drives pull through to multiple channels.”
Retail Velocity Runs on Search Answers
Most direct-to-consumer founders treat retail shelves as a brand billboard. They pay slotting fees, land in physical stores, and watch their inventory sit because retail shoppers do not behave like targeted social media users. AG1 is moving into nearly 10,000 stores across Walmart, Target, and Kroger with a different assumption: offline foot traffic buys what algorithmic search validates.
Cole points out the overlap: “The very thing that drives retail velocity and repeat is the same thing that drives sticky DTOC high LTV customers which is great experience great recommendation but is demand the actual demand generation that is increasingly coming from agentic search.”
When a shopper stands in an aisle at Target, they search their phone for direct comparisons. An answer engine points to formulation data and clinical backing. If your clinical proof does not exist in indexed research repositories, your retail distribution dies on the shelf.
Where AG1 Directs Automated Savings
Automation usually means cutting headcount to fatten gross margins before an exit. Cole took a different route. AG1 introduced agentic tools two and a half years ago to automate frontline customer support triage, track supply chains, and speed up formulation research.
“The opportunity that we started about 2 and a half years ago bringing in agentic tools into the business to not only manage costs, yes it can keep us from having to invest in and hire more people,” Cole says. “It also makes the people we have far more efficient. So we will spend less on traditional customer service and get incredible operating leverage because of AI tools, but we'll reinvest that into a much better customer experience.”
Instead of treating support automation as pure cost reduction, AG1 holds operating expenses flat. The company redirects payroll savings into clinical validation and retention programs. In an algorithmic discovery environment, funding another clinical trial generates far more long-term distribution than hiring another tier-one support representative or buying more paid social ads.
What to Do With This
Audit your primary product page through an answer engine tomorrow morning. Query Perplexity and ChatGPT for the specific problem your product solves, and see if your company appears in the cited sources. If the answer pulls third-party reviews and forum posts instead of technical papers or verified data, reallocate your next creator budget directly into independent product testing.